Latest stories, analysis, and insights from the world of health.
A small trial shows that heart patches engineered from induced pluripotent stem cells (BioVAT) thickened damaged heart walls and improved pumping ability in advanced heart failure patients, potentially serving as a bridge to transplant or left ventricular assist device implantation.
Saunas have been used for thousands of years across cultures, and modern research now supports their benefits for cardiovascular health, relaxation, and sleep. Learn what happens to your body in a sauna and how to incorporate sauna use into your wellness routine safely.
A small clinical trial shows that heart patches engineered from induced pluripotent stem cells can thicken damaged heart walls and improve pumping ability in advanced heart failure patients, offering potential as a bridge to transplant or device implantation.
Birth rates in England and Wales have fallen to their lowest level in nearly 50 years, with 585,000 live births in 2025, as people cite global uncertainty, rising costs, and lifestyle choices as reasons for having fewer or no children.
President Trump reports his latest medical and dental checkup went "PERFECTLY," marking his fourth publicly disclosed exam since returning to office. Meanwhile, physicians call for greater transparency and medically-grounded information about presidential health evaluations.
Young patients at a Middlesbrough mental health unit warned staff that someone would die, yet their concerns were ignored. Three teenagers subsequently took their own lives while under the care of Tees, Esk and Wear Valleys NHS Foundation Trust, prompting demands for a public inquiry into systemic failures.
Kyle Diamantas's FDA appointment receives praise while concerns grow over a leadership vacuum at the NIH, highlighting ongoing challenges in federal health agency management.
Former patients and families of those who died describe failures in mental health care at a North Yorkshire NHS trust, claiming teenage patients were ignored despite warnings of fatal consequences before a public inquiry was announced.
Former teenage patients of an NHS mental health trust describe being ignored and receiving inadequate care, with three young women taking their own lives within eight months, prompting calls for a public inquiry into systemic failures at the Tees, Esk and Wear Valleys NHS Foundation Trust.
President Trump, 79, is undergoing his fourth publicly disclosed medical exam at Walter Reed National Military Medical Center as questions about presidential health transparency and disclosure remain at the forefront, with the White House controlling what medical information becomes public.
Early data from Utah's five-month pilot program with AI startup Doctronic reveals the system renewed prescriptions 72% of the time without physician escalation, though independent review of the pilot's safety claims is still pending. The experiment tests whether AI can legally assist with prescription renewals while operating under the state's AI innovation regulatory sandbox.
Australia has confirmed its first diphtheria death since 2018 as the country experiences its worst outbreak of the vaccine-preventable disease in decades, with 245 cases reported in 2026 primarily affecting remote Indigenous communities.
Kyle Diamantas, the acting FDA commissioner, has earned significant trust and exceeded expectations in his role leading the regulatory agency during a critical period.
Australia has recorded its first diphtheria death since 2018 as the country experiences its worst outbreak of the vaccine-preventable disease in decades, with 245 cases primarily affecting remote Indigenous communities.
Eli Lilly announced that its gene-editing therapy VERVE-102 reduced cholesterol levels by 62% in Phase 1 clinical trial participants, with no treatment-related serious adverse events reported. The therapy, acquired through a $1 billion buyout of Verve Therapeutics, represents a potential one-time treatment to prevent heart disease.
The World Health Organization has raised the public health risk from the Ebola outbreak in the Democratic Republic of Congo from "high" to "very high," with nearly 750 suspected cases and 177 suspected deaths reported so far.
Eli Lilly has released Phase 1 trial data for VERV-102, a gene editing therapeutic designed to reduce cholesterol levels by targeting specific genetic pathways. The preliminary results represent a significant step forward in developing gene-based treatments for cardiovascular disease.
A new study reveals a dramatic rise in fake references in biomedical research, with fabricated citations increasing 12-fold since 2023, reaching a rate of one in 277 papers by early 2026, raising serious concerns about AI-generated misinformation in scientific literature.
Eli Lilly's experimental gene-editing therapy demonstrates early efficacy in Phase 1 trials for cholesterol management, marking a significant advancement in genetic treatment approaches.
Eli Lilly announced that its gene-editing therapy VERV-102 reduced LDL cholesterol by 62% in Phase 1 clinical trial participants, with no serious adverse events reported. The therapy, acquired in a $1 billion buyout of Verve Therapeutics, could offer a one-time treatment option for patients struggling with conventional cholesterol-lowering medications.